Alpha-fetoprotein (AFP) serves as the primary screening and diagnostic biomarker for HCC but suffers from limited sensitivity, as approximately 40% of HCC patients have normal AFP levels, and only 20% of those with early-stage HCC exhibit elevated AFP levels [7, 8]. Here, AFP is linked to hepatocellular carcinoma.